Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | ADH1B | P00325 | 3/20 | 0.38 |
| ▸ | ADH1C | P00326 | 3/20 | 0.38 |
| ▸ | ADH1A | P07327 | 3/20 | 0.38 |
| ▸ | ADH7 | P40394 | 3/20 | 0.38 |
| ▸ | ADH4 | P08319 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1410356 | 0.93 | TSHR (0.52) | TSHRALDH1A1FAAHTRPV1SMN1; SMN2 | |
| SCHEMBL27577002 | 0.91 | TSHR (0.56) | TSHRALDH1A1FAAHTRPV1ACE2 | |
| SCHEMBL1783042 | 0.91 | TSHR (0.56) | TSHRALDH1A1FAAHTRPV1ACE2 | |
| SCHEMBL13309278 | 0.91 | TSHR (0.56) | TSHRALDH1A1FAAHTRPV1ACE2 | |
| SCHEMBL11358374 | 0.91 | TSHR (0.56) | TSHRALDH1A1FAAHTRPV1ACE2 | |
| SCHEMBL13309277 | 0.91 | TSHR (0.56) | TSHRALDH1A1FAAHTRPV1ACE2 | |
| SCHEMBL28194813 | 0.91 | TSHR (0.56) | TSHRALDH1A1FAAHTRPV1ACE2 | |
| SCHEMBL1410276 | 0.91 | TSHR (0.59) | TSHRALDH1A1FAAHTRPV1SMN1; SMN2 | |
| SCHEMBL1786680 | 0.88 | TSHR (0.58) | TSHRALDH1A1FAAHTRPV1SMN1; SMN2 | |
| SCHEMBL10736358 | 0.87 | LMNA (0.46) | TSHRALDH1A1FAAHTRPV1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116375567-A | Method for manufacturing multi-branched high carbonic acid | 浙江信汇新材料股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| EP-3655466-A2 | STABILIZED BIOFILLER PARTICLES AND POLYMER COMPOSITIONS INCLUDING THE SAME | Xinova, LLC (US) | 2020-05-27 | — | — | EP | claimed |
| CN-110669107-A | Antibacterial peptide and preparation method thereof | 上海医药工业研究院 | 2020-01-10 | — | — | CN | claimed |
| EP-0074123-B1 | A PROCESS FOR PRODUCING A SINGLE CELL PROTEIN MATERIAL (SCP), SCP AND BIOLOGICALLY PURE CULTURE OF YEAST | PHILLIPS PETROLEUM COMPANY (US) | 1986-04-30 | — | — | EP | claimed |
| EP-4365159-B1 | ORGANOHALOGEN COMPOUND HAVING CONJUGATED DOUBLE BOND, PROCESS FOR PREPARING ACETATE COMPOUND AND ALCOHOL COMPOUND THEREOF, AND COMPOUND USED TO SYNTHESIZE THE ORGANOHALOGEN COMPOUND | SHINETSU CHEMICAL CO (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-12246310-B2 | Processes for recovery of rhodium from a hydroformylation process | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-03-11 | — | — | US | disclosed |
| EP-4054762-B1 | PROCESSES FOR RECOVERY OF RHODIUM FROM A HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-12-18 | — | — | EP | disclosed |
| US-20240174701-A1 | ORGANOHALOGEN COMPOUND HAVING CONJUGATED DOUBLE BOND, PROCESS FOR PREPARING ACETATE COMPOUND AND ALCOHOL COMPOUND THEREOF, AND COMPOUND USED TO SYNTHESIZE THE ORGANOHALOGEN COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-05-30 | — | — | US | disclosed |
| WO-2024100391-A2 | NEW ANTIBACTERIAL PRODUCTS | UNIVERSITY OF LIVERPOOL (GB) | 2024-05-16 | — | — | WO | disclosed |
| EP-4365159-A1 | ORGANOHALOGEN COMPOUND HAVING CONJUGATED DOUBLE BOND, PROCESS FOR PREPARING ACETATE COMPOUND AND ALCOHOL COMPOUND THEREOF, AND COMPOUND USED TO SYNTHESIZE THE ORGANOHALOGEN COMPOUND | Shin-Etsu Chemical Co., Ltd. (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117924017-A | Organic halogen compound having conjugated double bond, method for preparing acetate and alcohol derivative thereof, and compound for synthesizing the compound | 信越化学工业株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-110669107-B | Antibacterial peptide and preparation method thereof | 上海医药工业研究院 | 2024-04-02 | — | — | CN | disclosed |
| US-5998635-A | CATALYTIC CYCLIZATION AN ALDEHYDE WITH A KETENE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| EP-0583971-A1 | Piperidine derivatives | SANKYO COMPANY LIMITED (JP) | 1994-02-23 | — | — | EP | disclosed |
| EP-0251827-B1 | NEW CYCLIC ETHER DERIVATIVES, THEIR PREPARATION AND THEIR USE | Sankyo Company Limited (JP) | 1993-09-15 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |
| US-4891363-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | SANKYO COMPANY LIMITED (JP) | 1990-01-02 | — | — | US | disclosed |
| EP-0251827-A2 | New cyclic ether derivatives, their preparation and their use | Sankyo Company Limited (JP) | 1988-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174701-A1 | ORGANOHALOGEN COMPOUND HAVING CONJUGATED DOUBLE BOND, PROCESS FOR PREPARING ACETATE COMPOUND AND ALCOHOL COMPOUND THEREOF, AND COMPOUND USED TO SYNTHESIZE THE ORGANOHALOGEN COMPOUND | ADH5, ADH1C, ADH1A | TSHR 911/4885ALDH1A1 16/4885FAAH 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.